Search research articles
Contact Us
Filters
Showing results (101-110 of 175) with videos related to
Page
of 18
Sort By:
The Lancet. Gastroenterology & Hepatology
|
July 10, 2018
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis
Eric Nguyen-Khac, Maja Thiele, Cosmin Voican, et al.
Journal of Viral Hepatitis
|
August 29, 2022
Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real-world cohorts
Jordan J Feld, Xavier Forns, Douglas E Dylla, et al.
Blood Advances
|
August 11, 2020
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
Pierre-Edouard Debureaux, Bruno Cassinat, Juliette Soret-Dulphy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 5, 2020
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection
Eli Zuckerman, Julio A Gutierrez, Douglas E Dylla, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 15, 2022
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
Jérôme Boursier, Clémence M Canivet, Charlotte Costentin, et al.
Journal of Gastroenterology
|
May 18, 2013
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C
Jérôme Boursier, Victor de Ledinghen, Nathalie Sturm, et al.
Hepatology (Baltimore, Md.)
|
July 13, 2022
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD
Clémence M Canivet, Charlotte Costentin, Katharina M Irvine, et al.
Kidney International
|
May 9, 2018
Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective
Laurent Alric, Isabelle Ollivier-Hourmand, Emilie Bérard, et al.
Hepatology (Baltimore, Md.)
|
September 18, 2016
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values
Salvatore Petta, Vincent Wai-Sun Wong, Calogero Cammà, et al.
Journal of Hepatology
|
May 24, 2024
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms
Margarita Papatheodoridi, Victor De Ledinghen, Monica Lupsor-Platon, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 175) with videos related to
Sort By:
Page
of 18
The Lancet. Gastroenterology & Hepatology
|
July 10, 2018
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis
Eric Nguyen-Khac, Maja Thiele, Cosmin Voican, et al.
Journal of Viral Hepatitis
|
August 29, 2022
Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real-world cohorts
Jordan J Feld, Xavier Forns, Douglas E Dylla, et al.
Blood Advances
|
August 11, 2020
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
Pierre-Edouard Debureaux, Bruno Cassinat, Juliette Soret-Dulphy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 5, 2020
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection
Eli Zuckerman, Julio A Gutierrez, Douglas E Dylla, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 15, 2022
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
Jérôme Boursier, Clémence M Canivet, Charlotte Costentin, et al.
Journal of Gastroenterology
|
May 18, 2013
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C
Jérôme Boursier, Victor de Ledinghen, Nathalie Sturm, et al.
Hepatology (Baltimore, Md.)
|
July 13, 2022
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD
Clémence M Canivet, Charlotte Costentin, Katharina M Irvine, et al.
Kidney International
|
May 9, 2018
Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective
Laurent Alric, Isabelle Ollivier-Hourmand, Emilie Bérard, et al.
Hepatology (Baltimore, Md.)
|
September 18, 2016
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values
Salvatore Petta, Vincent Wai-Sun Wong, Calogero Cammà, et al.
Journal of Hepatology
|
May 24, 2024
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms
Margarita Papatheodoridi, Victor De Ledinghen, Monica Lupsor-Platon, et al.
Page
of 18